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1. Introduction
Endocytosis is critical for the internalization and maturation of many DNA viruses. Since all
non-enveloped DNA viruses replicate in the nucleus, they can also take advantage of endo‐
cytosis trafficking for transport from the cell surface to the nucleus. The internalization often
involves clathrin-mediated endocytosis (ClaME), but also macropinycytosis, caveolae-medi‐
ated endocytosis (CavME) and other less characterized internalization mechanisms. Viruses
strive to avoid evidence of cell entry, and thus of immune attack, and therefore as much as
possible take advantage of existing systems. Consequently, virus entry has been extensively
studied to understand endocytosis. In contrast to inert cargo, like dextran, well-defined vi‐
rus particles can be mutated to change biological properties, e.g. receptor interaction, matu‐
ration steps or penetration of the endosomal membrane to the cytosol, and thus provide
additional tools for the study of endocytosis. However, the use of viruses also poses major
challenges since (i) the virus particle population may be heterogeneous; (ii), only one out of
a thousand particles may be infectious; (iii), viruses may be using different pathways at the
same time; (iv), viral entry pathways may depend on the cell types used; (v), some viruses,
eg. papillomaviruses are difficult to reproduce in tissue culture; (vi) the mobility of the in‐
fecting particles may be heterogeneous; and (vii), viruses often developed mechanisms to
avoid infected cells (e.g. viral neuraminidases). The use of purified viruses and cell cultures,
although imparting useful models, may not reproduce the in vivo situation. Moreover, virus‐
es may have adapted to in vitro cells and may use other pathways then in vivo. In this chap‐
ter, we focus on entry of non-enveloped DNA viruses, such as circoviruses, parvoviruses,
polyomaviruses, papillomaviruses, adenoviruses and iridoviruses. Particularly, we will
highlight the effects of binding of these viruses to the cell surface, the internalization and
endocytosis processes, and escape from endosomes by breaching the endosomal barrier. The
wide array of strategies employed by these viruses, even within the same virus family, will
be highlighted. An understanding of these processes, which may result in a plethora of ef‐
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fects on cells, is essential for a wide variety of applications in basic research as well as pro‐
viding blueprints for applied usages such as gene therapy.
2. Overview of non-enveloped DNA viruses and tools to study their entry
2.1. Non-enveloped DNA viruses
Viruses can be used as a tool to study endocytosis since their defined structure can be modi‐
fied specifically by site-directed mutagenesis to study different parts of the endocytic path‐
ways. Functions related to virus entry are embedded in the virus capsid. Therefore, we will
summarize here the structures and properties of these viruses. All, except the iridoviruses,
have been solved by X-ray crystallography and their properties are recapitulated in Table 1.
2.1.1. Circoviruses
Circoviruses are among the smallest DNA viruses; the diameter of the icosahedral particle is
about 20 nm. The virus has a circular, 2 kb single-stranded DNA genome (ssDNA). The T=1
capsid consists of 60 subunits (1, 2). The best-known species infect pigs and birds. Soluble
monomers of the porcine circovirus 2 (PCV2) capsid have been expressed in E.coli and could
be assembled into virus-like particles (VLPs). X-ray crystallography (2) revealed two protru‐
sions emanating from the icosahedral 2- and 5-axes. PEPSCAN analysis (3) and structural
analysis (2) identified 4 surface epitopes, two epitopes at the subunit interface near the 3-
fold axis and two at the interior surface. The interior epitope mapped to the N-terminus of
the subunit, which, as for parvoviruses and some other animal viruses, may be transiently
externalized. This domain may have membrane-disrupting activity required for infectivity.
PCV2 binds to heparan sulfate receptors on cells (4). Clefts that bind sulfate ions, and are
positively charged at neutral pH, on the exterior surface of the PCV2 structure surrounding
the 2-fold axis are highly conserved. Heparan sulfate may thus bind to this region.
2.1.2. Parvoviruses
The icosahedral viral capsid of parvoviruses infecting vertebrates is made up of two or three
proteins that have large common C-terminals part and different N-terminal extensions, due
to different translation initiations or proteolysis. The rugged capsid structure is very resist‐
ant to acids, bases, solvents such as chloroform or butanol, and temperatures to beyond 50
C. The X-ray structures of many parvoviruses have been solved, but these structures lack the
N-terminal extensions (5-10). Parvoviruses, such as the minute virus of mice (MVM), pack‐
age their linear ssDNA genome into preformed capsids, in a process that is probably driven
by a virus-encoded NS1 (helicase). Each of the twelve 5-fold vertices have a roughly cylin‐
drically shaped pore created by the juxtaposition of 10 antiparallel beta-strands, two from
each of the 5-fold-related capsid proteins. Mutant capsids that have their 5-fold channels
blocked are unable to package DNA, strongly suggesting that the 5-fold pore is the packag‐
ing portal for genome entry (11). It may also be the DNA delivery site after the conforma‐
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tional changes occurring in these pores in the endosome. Virtually all parvoviruses also
contain a phospholipase A2 activity (PLA2) in the N-terminal extension of the largest capsid
protein (12, 13). This domain is located inside the capsid and needs to be externalized for it
to be able to breach the endosomal membrane barrier (12). These multistep conformational
changes occur in the endosomes.
Family Structure2 Capsid composition Entry mode Escape
Circoviridae1 PDB : 3R0R
T=1
60 proteins/subunits
20 nm
ClaME
Uncoating by
serine
proteases;
Escape early
(not at very low
pH)
Parvoviridae1 PDB : 2CAS
T=1
60 proteins/subunits
25 nm
Majority: ClaME
Also: CavME
Macropino-
cytosis
CLIC/GEEC
LE / lysosomes
Viral PLA2
activity
Polyomaviridae1 PDB : 1SVA
T=7
360 VP1 proteins
(72 capsomers)
45 nm
CavME
ER, Viral VP2
cellular
proteins BAP31
and BiP
Papillomaviridae1 PDB : 1L0T
T=7
360 L1 proteins
(72 capsomers)
55 nm
Majority :
ClaME
Other :
CavMEMacropi
no-
cytosis
Cellular
Nexin-17
viral capsid
protein L2
Adenoviridae1 PDB : 1VSZ
Pseudo-T=25
720 hexon proteins
(240 subunits)
12 penton bases
Cement proteins
Fiber proteins
90 nm
Majority :
ClaME
Others :
Macropino-
cytosis
Sorting
endosomes
Penton base,
L3/p23
protease,
protein VI.
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Iridoviridae PDBe3 : 1580
T=147
1460 hexon proteins
(each forms trimer)
12 pentameric
vertexes
Fiber proteins (CIV)
185 nm
ClaME
CavME
May involve
partialuncoatin
g and internal
membrane
Table 1. Synopsis of nonenveloped DNA viruses and entry and exit of endosomes
2.1.3. Polyomaviruses
The 45 nm diameter T=7 icosahedral particles polyomaviruses virions (SV40, BK virus) are
non-enveloped. The crystal structure of SV40 has been solved and found to be organized un‐
like other viruses (14-16). The 3 capsid proteins, VP1-3, form 72 pentameric capsomers, 60
hexagonally coordinated plus 12 pentamerically coordinated (at the vertices), i.e. the cap‐
somers at the 5-fold axis have all 5 neighboring capsomers whereas the other 60 have 6 cap‐
somer neighbors via different intercapsomer interactions. The 72 pentameric capsomers in
each virus particle contain together 360 copies of VP1 plus 30-60 copies each of VP2 and
VP3, i.e. ~1 copy in the tapering cavity inside of each pentamer. VP2 is important during cell
entry. Each copy of VP1 has a sialic acid binding site on the surface and these are part of the
receptor-binding site for the virus; hence the particles have haemagglutinating properties.
The long C-terminal arms of VP1 stabilize the interpentameric contacts by invading neigh‐
boring capsomers. VP2 is myristylated at its NH2-terminus, and is also believed to be im‐
portant in holding the particle together (17). Recently, it was also shown that the cysteine at
position 9 in VP1 forms C9-C9 disulfide bonds and thus contributes to intercapsomeric
crosslinks (18).
2.1.4. Papillomaviruses
Previously, the Papovaviridae family contained both the Papillomaviridae and the Polyoma‐
viridae. Now, these two are separate families but their earlier co-classification indicates a
certain degree of similarity (19, 20). The diameter of the papillomaviruses is about 20% larg‐
er than that of polyomaviruses, mainly due to the larger L1 as compared to VP1 (21, 22).The
atomic structure resembles that of polyomaviruses (23), in particular the core capsomers,
and the 55 nm diameter T=7 icosahedral particles also have 72 pentameric capsomers (20, 24,
25). However, the cysteine residues involved in intercapsomer disulfide bonds are C175 and
C428 (23).
2.1.5. Adenoviruses
The over 50 serotypes of the Adenoviridae family can be categorized in about 6 subgroups.
The icosahedral outer capsid of these viruses surrounds a (double stranded) dsDNA-protein
core and has a diameter of about 90 nm (26). The most prevalent protein in the capsid are
720 subunits of hexon proteins arranged in 240 trimers (12 hexon trimers on each of the 20
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facets); penton base proteins are found at each of the 12 vertices. A unique "spike" or trimer‐
ic fiber is associated to each of these penton bases. Moreover, the penton base contains an
exposed arginine-glycine-aspartate (RGD) motif and both this motif and the fiber are in‐
volved in cell attachment. Minor capsid proteins (III, VI, VIII and IX) are also present to sta‐
bilize the capsid. The pseudo-T=25 capsid is the largest virus so far of which the near-atomic
structure has been solved by X-ray crystallography (27, 28). The fibers were shortened in or‐
der to make crystallization possible. An unusual symmetry mismatch occurs between the fi‐
vefold symmetric penton base and the threefold symmetric fiber protein. This has a
potential impact on cell receptor interactions and subsequent disassembly in the endosomal
pathway. In this respect, the ability of the penton base to adapt large changes, resulting in
very different central pore sizes, is striking. The large-pore, but not the small-pore, confor‐
mation would allow insertion of the fiber. These conformational changes seem to reflect ear‐
ly events in cell entry when the fiber is released from the penton base.
2.1.6. Iridoviruses
Iridoviruses have recently been reviewed in detail (29). Currently, the Iriodviridae family is
divided into five genera: Iridovirus, Chloriridovirus, Ranavirus, Lymphocystivirus, and Megalo‐
cytivirus. Chilo Iridescent Virus (CIV) is the type specie of this family. Although, it is unlike‐
ly that the structures of these large icosahedral dsDNA viruses are amenable to X-ray
crystallographic analysis, various details about their assembly and structure have been ob‐
tained by cryo-electron microscopy (cryo-EM) and 3D reconstruction (30, 31). Enveloped
particles that acquire an envelope by budding from the plasma membrane seem also to exist
for all iridoviruses and may be more infectious than naked particles (29). The CIV T=147
capsid has a diameter of about 185 nm. Its dsDNA-protein core is surrounded by a lipid bi‐
layer, derived from the endoplasmic reticulum that follows the contour of the outer icosahe‐
dral capsid shells. The external capsid is essentially consistent with the classical
quasiequivalent symmetry prediction. It has 1460 hexameric capsomers and 12 pentameric
vertex complexes that are organized in 20 trisymmetrons and 12 pentasymmetrons. Each
capsomer in CIV, but not in frog virus type 3 (FV3), has a central fiber that appears to be
extended about 35 nm beyond the capsid surface. These flexible fibers are probably the first
component that comes into contact with the host cell. The minor zip and finger proteins are
suggested to stabilize the capsid by acting as intercapsomer cross-links and could be impor‐
tant during virus conformational changes during entry. Furthermore, the minor anchor pro‐
tein appears to extend into the internal lipid membrane for further stabilization. Although
the inner membrane is generally 4 nm thick, it is only 3 nm in regions just below the pen‐
tameric complex. Small icosahedral viruses are usually assembled from monomers having
hexamers and pentamers, or only pentamers, in quasi-equivalent environments. The larger
viruses, like adenovirus, iridoviruses and large algal and bacterial viruses, have significantly
greater coding capacities that have allowed divergent evolution and specialized pentameric
complexes. In contrast to adenovirus, CIV does not have fibers associated with its pentame‐
ric complexes but a complex mushroom-like structure that has the appearance of a five-
blade propeller. This propeller could have an important role in assembly but a role in entry
is not excluded.
Endocytosis of Non-Enveloped DNA Viruses
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2.2. Tools used to study endocytosis and trafficking of viruses
2.2.1. Imaging
Transmission electron microscopy (TEM) is still widely used, and enables visualization of
virus in endocytic cups (size and shape, presence of coats). For instance, TEM imaging dem‐
onstrated that Adeno-associated virus 5 (AAV5) can enter cells in non-coated vesicles, point‐
ing to a non-clathrin mechanism (32). Immunohistochemistry using gold-labeled antibody
can be used in TEM to colocalize structures. Scanning electron microscopy (SEM) facilitates
3D imaging that can be helpful to see ruffles on cell surface, as shown in an AAV2 study
(33).
Fluorescence, particularly confocal microscopy, is an excellent tool to visualize viruses and
cellular structures. It is frequently used to confirm use of a pathway by co-localisation of the
virus and pathway components. It can also be used in live imaging to see the movements of
the virus along cellular structures, such as plasma membrane (filopodia) and actin or tubu‐
lin structural networks. One should be aware that conformational epitopes may change dur‐
ing the endosomal pathway and that some viruses have very high GCE/FFU ratios (genome
copy equivalent/foci forming unit), so that an excess of non-infectious virus in the viral
preparation could mask the real infectious pathway. For further details, see chapter by Aar‐
on and Timlin.
2.2.2. Chemical inhibitors
Chemical inhibitors are widely used and provide an excellent basis for endocytosis studies
of a particular cargo (34) (Table 2). These are usually not expensive, easy to work with, and
have the major advantage of providing a uniform treatment of the cells. None of the exten‐
sively used pharmacological inhibitors have complete specificity, but, some parameters can
be controlled to limit the possibility of artefacts. Dose-response curves to establish lowest
concentrations and shortest exposition times possible to limit side effects on the cells are val‐
uable, and limit upregulation of compensatory mechanisms. It is also easy to wash out the
inhibitors to recover a normal state of the cells, in the case of reversible inhibition. This also
remove virus that did not yet penetrate the cells, and allows continuing the infection with
only endocytosed virus in normal conditions of the cells. Confirmation with another inhibi‐
tor, without the same side effects, is convenient. A combination of methods with siRNA or
dominant negative/constitutive mutants can be exploited to identify the entry pathway of a
specific cargo. Readers are referred to selected literature for further details on any particular
inhibitor for comprehensive discussions (34, 35).
2.2.3. Dominant-negative/constitutive mutants
Dominant-negative mutants drive the expression of non-functional versions of the protein of
interest (Table 3). The regular protein is still present but strong expression of the mutant
form will result in an inactive pathway (35). The main challenges using dominant-negative
mutants is to choose the appropriate protein and to achieve high efficiencies in the transfec‐
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tion of the constructs. Stable transfection, with selection of the transfected cells, is not a good
choice, since long (constitutive) treatments that donwnregulate a pathway is prone to result
in the upregulation of compensatory pathways that could be used by the cargo. Using domi‐
nant-negative mutants can also be more time-consuming and become more costly than
chemical inhibitors. A constitutively active protein can block a pathway at a certain step, e.g.
constitutively active Rab5 protein inhibits the passage from early endosomes and late endo‐
somes (see section 4.2.2.). There is also a complex signalisation process involved in endocy‐
tosis, and any modification can have some side effect on the cells.
Pathway Inhibitor Mechanism of action Side effect
Clathrin Hypertonicsucrose
Dispersion of clathrin
sub-units, preventing
basket formation
Inhibits CavME and
macropinocytosis (high
doses);Induces important
remodelling of the actin
network
Chlorpromazine
Clathrin and AP2
relocalized at the
endosomes
Inhibits phagocytosis and
formation of large vesicles
Potassium
depletion
Prevents clathrin
basket formation
Reduces other non-clathrin
endocytosis mechanisms;
Alteration of actin cytoskeleton
Cytosol
acidification
Blocks budding of
vesicles
Inhibition of macropinocytosis;
Alters actin cytoskeleton
Caveolae Nystatin
Induces cholesterol
sequestration and
aggregation
Can affect macropinocytosis at
high concentrations
Methyl-β-
cyclodextrin
Disperse cholesterol,
mislocalisation of
caveolin-1
High concentration leads to
inhibition of ClaME and fluid
phase endocysotis;
Affects actin structure
Cholesterol
oxydase
Relocalization of the
caveolin-1 to the
Golgi
Action of the enzyme is
sensitive to several factors that
may lead to false negatives
Macropino-
cytosis Amiloride
Inhibits Na+/H+-
ATPase exchangers;
Prevents membrane
extension formation
Can affect ClaME;
Can reduce lipid raft
internalization;
Alters actin structure
Cytochalasin D Prevents membraneprojection by actin
Other mechanisms depend on
actin and membrane modelling
Endocytosis of Non-Enveloped DNA Viruses
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Wortmannin
Inhibition of PI3K,
important for
formation and fusion
of vesicles
Not exclusive for
macropinocytosis
Acidification of
endosomes Bafilomycin A
Block the V-ATPase
proton pumps
No effect on recycling pathway,
prevents transfer from EE to LE
Weak base
(NH4Cl,
chloroquine)
Gently raise the pH of
the compartment;
Does not affect the transport of
cargo to the lysosomes
Table 2. Chemical inhibitors to study endocytosis of viruses
Pathway /
component Protein Mode of action
ClaME EPS15 Deletion of EH domains results in loss of recruitment ofclathrin and AP2 at endocytosis site (36)
Clathrin Overexpression of the HUB domain in the cells leads to theinhibition of the cage assembly at endocytosis site.
CavME Caveolin-1
Overexpression of the WT protein stabilizes the caveolin
structure located at the plasma membrane, thus prevent
membrane curvature and/or vesicle budding
Caveolin-3 Deletion of N-terminal, or fusion with EGFP in N-terminalinhibits endocytosis (37)
Dynamin Dynamin-1/Dynamin-2
K44A is widely used. Dynamin is involved in ClaME, CavME
and other less described non-ClaME/ non-CavME
mechanisms
Macropino-
cytosis Pak-1 Important in the regulation of vesicle cycling
Rac-1 Important for membrane ruffling, inhibited withN17Rac1(33); Blocks cell cycle in G2/M phase
Other
pathways GRAF1
Key player in the newly described CLIC/GEEC pathway (33,
38)
Table 3. Dominant-negative / constitutive mutants
2.2.4. Gene silencing
Another way to target a particular protein, as opposed to chemical inhibitors and dominant-
negative mutants, is gene silencing. Several endocytosis studies use transfection of small in‐
terfering RNA (siRNA) or small hairpin RNA (shRNA) to specifically knock down key
proteins of different endocytosis pathways (see section 4.3). This method is relatively simple
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and selective, but depends on good delivery of the interfering RNA. A good knockdown of
the target protein needs to be confirmed by Western blot analysis, and only then can endo‐
cytosis studies can be performed. However, since there are some entry pathways not fully
described yet, it remains a possibility that some proteins that we believe specific to a certain
entry mode will be demonstrated in the future to be involved with other pathways.
3. Docking of virus to cell surface and induced signalling pathways
3.1. Virus attachment to cells
The first interaction between a virus and a cell is crucial to promote endocytosis. In its sim‐
plest form, the virus binds to a cell surface receptor and triggers directly its endocytosis.
However, several viruses have either multiple receptors, or they also bind abundant struc‐
ture on the cell surface, e.g. as sialic acids, before binding to the “real” receptor. In its most
sophisticated form, the virus needs to bind to a primary receptor to trigger conformational
changes that will allow binding to a secondary receptor that will in turn trigger endocytosis.
Binding to the cell surface is also the first element that can determine viral tropism, if the
virus uses a specific receptor present only on certain cell type.
3.1.1. Cell attachment by circoviruses
Monocyte/macrophage lineage cells are target cells PCV2 replication. Misinzo et al. (4) used
the porcine monocytic cell line 3D4/31, that supports PCV2 replication in vitro, and glycosa‐
minoglycans (GAG), used by several viruses as receptors, for attachment studies. They ob‐
served that heparin, heparan sulfate (HS), chondroitin sulfate B (CS-B), but not CS-A, and
keratan sulfate reduced PCV2 infection when these GAG were incubated with PCV2 prior to
and during inoculation of 3D4/31 cells. Also, enzymatic removal of HS and CS-B prior to
PCV2 inoculation of 3D4/31 cells significantly reduced PCV2 infection. Similarly, when
PCV2 virus-like particles (VLP) were allowed to bind onto 3D4/31 cells in the presence of
heparin and CS-B, attachment was strongly reduced. This was confirmed for the wild-type
virus. Together, these results demonstrated that HS and CS-B are components of the attach‐
ment receptors for PCV2.
3.1.2. Cell attachment by parvoviruses
The Parvoviridae family is very large, and its members infect a wide range of hosts from in‐
vertebrates to vertebrates such as humans. Family members display different strategies to
complete their replication cycle. Most parvovirus interactions with cells are neuraminidase-
sensitive, indicating binding to abundant sialoglycoproteins, e.g. porcine parvovirus (PPV)
(39), dependoviruses (AAVs) (40), minute virus of mice (MVM), canine (CPV) and feline
(FPV) parvoviruses (41). These glycan-specific interactions occur usually in the depressions
around the twofold symmetry axes. Specific receptors are not currently known for all parvo‐
viruses. One of the best characterized interactions is between CPV/FPV and the transferrin
Endocytosis of Non-Enveloped DNA Viruses
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receptor (TfR) (42). CPV and FPV is a well-documented evolution of virus characterised by
species jump. Thus FPV, a virus that can infect only cats, acquired two mutations on the cap‐
sid protein, enabling the binding to the canine TfR and thus emerge as CPV2, a virus that
could only infect dogs, and that caused serious health problems in dogs in the late 1970’s.
Shortly after, the CPV2a emerged and this virus was able to infect both species, because it
could bind to both receptors. PPV, that can bind and enter many cell types, but that can
complete the replication cycle only in few cell types (43).
3.1.3. Cell attachment by polyomaviruses
SV40 binds cell surfaces via major histocompatibility complex 1 (MHC-1) (37). This binding
provokes the clustering of the virus in lipid rafts, and entry by CavME. Infection can be effi‐
ciently inhibited by pre-incubation of the cells with antibodies directed at the MHC-1. It was
observed that initial binding (when endocytosis is inhibited by incubating the cells at 4 C)
occurs outside of the lipid raft, and that at that point, there was no co-localisation with cav‐
eolin (37). However, when the cells are at 37 C, translocation to the caveolin-positive domain
is fast and efficient.
3.1.4. Cell attachment by papillomaviruses
Uptake of papillomaviruses is very slow, and the virus can stay at the cell surface for several
hours and the half-time of uptake can be as high as 14 hours. A major issue with this family
of viruses that have slowed progress in their research was that, in the host, viruses only
complete their replication cycle in terminally differentiated keratinocytes (44). Thus, it was
only since the 2000’s that virus could be efficiently produced, using “packaging cell lines”
(45, 46). It is also hard to infect cells in vitro, since there are only a few permissive cell lines
such as the HaCaT cells. There is still limited information concerning the uptake and nuclear
delivery of those viruses. Concerning binding, growing evidence suggests that the extracel‐
lular matrix (ECM) can provide the first binding of the virus. Capsid protein L1 binds to the
heparan sulfate proteoglycans (HSPG), or laminin 5 present in the ECM. Then the virus is
transferred to the cellular filopodia, and slowly translocated to the body of the cell. Binding
to this primary receptor will trigger conformational changes, lowering affinity for the pri‐
mary receptor, and allowing binding to a still unidentified secondary receptor. The minor
L2 capsid protein, usually not accessible at the virus surface will become exposed, and
cleaved by cellular furin. This cleavage is absolutely required for successful infection and it
is believed to be important later in the endosomal escape. Although in vitro binding to the
surface receptor is critical, the in vivo situation is different in that the basement membrane is
the primary site of binding (47).
3.1.5. Cell attachment by adenovirus
The first high-affinity interaction between the cell and the virus occurs between the globular
knob of the C-terminal segment of the viral fiber protein and the cellular CAR (Coxackie
and Adenovirus Receptor, belonging to the Ig superfamily) or CD46, for sub group C and B
adenovirus respectively. The second interaction, of low affinity is between the RGD motive
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on the viral penton base and the cellular integrins. Together they will form a strong and irre‐
versible connection between the cell and the virus, leading to endocytosis (48).
3.1.6. Cell attachment by iridovirus
Little is known about iridovirus receptors; although the central fibers of the capsomers have
been proposed to be involved (31) not all iridoviruses have these fibers. Eaton et al. showed
that anti-FV3 serum present at the time of FV3 (Ranavirus) infection enhances infectivity of
the virus in non-immune teleost cell lines, but not in a non-immune mammalian cell line,
suggesting a cell surface receptor specific to teleost cell lines (49). They observed that this
antibody dependent enhancement (ADE) of FV3 was dependent on the Fc portion of anti-
FV3 antibodies but not to complement.
3.2. Induced signalling pathways
Signalization from cell surface is an important process in coordination of different events of
an organism. Readers are referred to two extensive reviews on the subject for further details
(50, 51). Signalling also regulate endocytosis processes. Binding to a receptor can trigger sig‐
nalling pathways that promote endocytosis by upregulating the quantity of clathrin at the
cell surface. Src kinase was shown to increase new clathrin basket formation by phosphory‐
lation of the clathrin, leading to assembly of the triskelions (52). Activation of p38 increases
Rab5 recruitment to plasma membrane, promoting endocytosis (53). Raf kinase is implicated
in recycling of the transferrin receptor to the cell surface (54). In the case of viruses, binding
of the virus to the cell surface receptor can trigger other endocytosis mechanisms such as
macropinocytosis which is not a constitutive process (55). Differential endocytosis can also
be used by the cell to control the level of signalling. For example, activated EGFR can be en‐
docytosed by ClaME or CavME. CavME is used when the level of activation is particularly
high and lead to degradation of the receptor, while ClaME leads to recycling of the receptor.
4. Entry mechamisms
4.1. Initial steps of entry
Viruses have developed multiple ways to hijack cellular entry processes ideally without any
remaining trace at the cell surface to prevent detection by the immune system. The three
best understood mechanisms are clathrin-mediated endocytosis (ClaME), caveolae endocy‐
tosis (CavME) and macropinocytosis (Figure 1).
Endocytosis of Non-Enveloped DNA Viruses
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Figure 1. Major endocytosis pathways. Major components of 3 most described endocytosis mechanisms. Main intra‐
cellular targets are indicated (e.g. early endosome for most, but also others such as endoplasmic reticulum and Golgi
for the CavME
ClaME is probably the best characterized cellular uptake mechanism. Cellular uptake was
first observed using transmission electron microscopy (TEM) in the 1960’s. One main char‐
acteristic is the assembly of clathrin proteins forming basket shape vesicles. As a result it
was postulated that the size of material that can be taken via ClaME is limited in order to
form the basket clathrin cage. ClaME proceeds in five steps (56). First, it requires specific re‐
ceptor engagement to trigger intracellular signaling required for the beginning of membrane
modeling, a process called “nucleation”. The key element is the highly conserved adaptor
protein AP2, recruited from the cytoplasm to the membrane. The next step is the “cargo se‐
lection”. At this stage there will be several interactions between the cargo, its receptor and
several adaptor and accessory proteins. The tetrameric AP2 adaptor protein, like clathrin,
has disproportionally large numbers of interactors, such as dynamin and Eps15, and is a
hub of protein networks. Accessory proteins may swap from the AP2 appendage hub to the
clathrin hub during coated pit assembly. Clathrin protein will also be recruited at the mem‐
brane in the “clathrin coat assembly” step. Clathrin proteins are recruited as triskelions and
will be polymerized into the basket shape forming pentagons and hexagons. When the poly‐
merization reaches the point where only a neck shape remains between the forming coated
vesicle and the plasma membrane the dynamin protein will be recruited to perform the
“vesicle scission” step required for the budding. GTP hydrolysis will be necessary to com‐
plete the process. The final step will be the “uncoating and recycling” step. This uncoating is
important before the nascent vesicle can move on and fuse with the endosomes. After this,
there will be a sorting step deciding whether the vesicle is simply returned to the plasma
membrane or pushed forward into the endosomal pathway.
CavME main characteristic is its origin in lipid rafts, small domains rich in sphingolipids
and cholesterol (57). This endocytosis mechanism thus depends on cholesterol homeostasis
of the cell. Caveolin is a membrane protein that binds to the cholesterol, as a result depletion
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of cholesterol leads to mis-localization of caveolin and inhibition of the pathway. Several
components are involved such as caveolin-1 (caveolin-2 can be present but not required,
caveolin-3 is present primarily in muscles), dynamin and actin (implicated in caveolin ri‐
gidity/motility). Vesicles acquire caveolin coats while forming; the released caveosomes will
keep a neutral pH and can interact with the endosomal pathway, the Golgi system, or as in
the case of SV40 endocytosis, transit to the smooth endoplasmic reticulum (37).
Macropinocytosis is an active uptake pathway that requires activation in most cells types
(58). Activation of the pathway will lead to intense actin and microfilaments modulation
and membrane ruffling. By definition pinocytosis is the uptake of fluids and membranes by
the cell (“fluid phase endocytosis”). The main difference with other endocytosis mechanisms
is that, once activated, uptake of material will not depend on receptor binding. In macropi‐
nocytosis, the membrane ruffles will or will not be closed and the size of the macropinosome
is not directed by the cargo. The diameter will usually range between 0.5 to 10 µm, and thus
is larger than in other endocytosis mechanisms. In contrast to phagocytosis, that is limited to
few cell types, most cells are capable of macropinocytosis. The closure of the macropino‐
somes will require several cellular factors. Myosins will provide contractile activity, and fu‐
sion factors together with kinases, GTPases, will help the process. Once in the cytoplasm,
macropinosomes will acidify and interact with the endosomal pathway.
Phagocytosis is a pathway limited to specialised immune cells such as macrophages, den‐
dritic cells, neutrophils and monocytes. This pathway is mostly used by bacteria and fungi.
Recent studies reported the use of this pathway also by herpes simplex virus (59) and mimi‐
virus (60), both displaying membranes. The non-enveloped DNA viruses that fall in the
scope of this chapter do not use it.
Novel pathways were revealed by investigating entry mechanism of viruses. They are often
referred to as clathrin independent endocytosis. Since molecular components involved in
these mechanisms depend not only on cargo but also on cell type, several groups suggested
classifying them as dependent or independent of such components. For example, no matter
which mechanism is involved the forming vesicle will need to be pinched of the cellular
membrane. While ClaME, uses dynamin proteins some clathrin-independent endocytosis,
were reported to be dependent on dynamin and some are independent.
4.2. Endosomal pathway
Regardless of the endocytosis pathways, virtually all the vesicles formed during entry will
fuse or at least interact with the early endosomes, and acquire the Rab5 and EEA1 markers
(61). After endocytosis, cargos enter the highly-coordinated endosomal pathways (62). Gen‐
eral endocytosis is a highly active and dynamic process. In a mammalian cell up to 180%, of
the cell surface will be endocytosed each hour (62). A simple model of the endosomal path‐
way is shown in Figure 2.
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Figure 2. Endosomal pathway. Most endocytosis mechanisms lead to the early endosomes. Sorting will determine if
the vesicle is recycled to the cell surface, caveosomes or continue in the degradation pathway towards the lysosomes.
Acidification occurs throughout the endosomal pathway. Crosstalk between the trans-Golgi network (TGN) and the
different compartments provides cellular components to the pathway. Transport of the vesicles on microtubules en‐
sures steady traffic towards the nucleus. Rab proteins are regulators of the pathway and can be used as markers.
The first compartment encountered is the early endosome (EE) which is slightly acid
(pH~6.5), highly pleomorphic, large and tubular shaped. The EEs are the main organelle
where sorting will take place. The main markers of EEs are Rab5 and EEA1 proteins. The
tubular projection contains microdomains for sorting, and will generate vesicles targeted to
the recycling endosomes (with Rab4 and Rab11), or the trans-Golgi network (TGN). The
TGN is constantly communicating with the endosomes at all stages of the pathway. It pro‐
vides components necessary for the maturation of the endosomes. A marker for the shuttles
between the TGN and the endosomes is Rab9. All endosomes contain internal vesicles that
are used to isolate certain components such as receptors. While endosomes proceeds to the
end of the pathway, these internal vesicles increase greatly in numbers. It has become clear
for polyomaviruses and papillomaviruses that EE shuttle also to caveosomes (section 5). Ma‐
turation of the EEs into late endosomes (LE) includes replacement of the Rab5 proteins by
Rab7 proteins (63). The maturation of EE in LE will create intermediate endosomes contain‐
ing both Rab5 and Rab7 markers. The displacement of Rab5 by Rab7 begins by the recruit‐
ment of Rab7 by the activated form of Rab5. This recruitment will lead to the inactivation
and dissociation of Rab5. This sequence is absolutely required for EE conversion into LE.
The newly formed Rab7-positive endosomes will recruit specific proteins for the maturation
of the LE.
LEs have an increased regular oval shape, their pH is more acidic (pH~5.5), and they contain
many internal vesicles (62). LEs are generated close to the cell surface and will mature while
moving towards the nuclear periphery. Fusion events will occur between LEs, and between
LE and lysosomes. The lysosome is highly acid (pH<5) and contains various hydrolases.
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Acidification of the endosomes is provided by proton pumps within the membrane of the
endosomes, the V-ATPases. The gradual acidification of the pathway is regulated by the
concentration of these pumps, the isoforms present, and the presence of other complexes.
Markers of the lysosomes are the LAMP proteins. In addition to transport of cargo to the
lysosomes, there is also transport of cellular components to the lysosomes. The different hy‐
drolases and membrane proteins are renewed to conserve the lysosome integrity, acidic pH
and activities. Transport comes mostly from the TGN via the late endosomes. Mobility of the
endosomes is dynamic, and involves both major transport on actin and the microtubule (Mt)
networks. Also, transport is not unidirectional, but oscillating, since the vesicles interact
both with the kinesins (transport toward cell periphery) and the dyneins (transport toward
nucleus) on the Mts. As the maturation of the endosomes proceeds, the net movement will
be toward the nucleus (64). Movement of the LEs toward the nucleus is important to reach
the lysosomes (mostly located in the nuclear periphery). The actin network is also important
for transport of the EEs to the LEs, and to generate small vesicles from the EEs that are tar‐
geted to the TGN or from LEs toward lysosomes. Actin is also important for fusion between
the LEs and lysosomes.
There are more than 60 different Rab GTPases that have specific membrane localizations.
Rab small GTPases are important regulators of the endosomal pathway (65) and thus they
can be used as markers, or as inhibitors of specific parts of the pathway by expression of
dominant-negative form. The regulation switch is the association of the Rab protein with ei‐
ther GDP or GTP, (66). Rab proteins are involved in multiple events. Rab5 is implicated in
the recruitment of the clathrin subunits, with other regulator proteins, such as GAPGDI, will
enable uncoating of the vesicle. Rab proteins were also shown to interact with actin (myosin)
and microtubule (dynein and kinesin) motors. An example is the Rab11 family of proteins
that link recycling vesicles to myosin (67). Also an effector of the Rab7 protein interacts with
the dynein motor to promote minus-end traffic on the microtubules, transporting late enso‐
somes toward the lysosomes. Membrane fusion also involves several proteins, including the
Rab protein, and SNAREs (soluble NSF attachment protein receptor) (68). In this case Rab
protein could mediate targeting of the appropriate membrane and docking of the mem‐
branes, for SNAREs to achieve fusion event.
4.3. Pathways selected by various non-enveloped DNA viruses
Members of the same family or the same genus may use different pathways. There is grow‐
ing evidence that certain viruses evolved the use of multiple entry pathways. This can be an
advantage to infect different cell types. However, it can be difficult to determine whether
multiple entry pathways are involved or if one complex pathway use different components.
Often viruses can have multiple sequential binding to the cell surface, which can trigger dif‐
ferent signaling pathways inside the cell, calling for components normally observed to drive
different entry pathways.
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4.3.1. Endocytosis of circoviruses
Porcine circovirus (PCV) infects a wide variety of cell types, including hepatocytes, cardio‐
myocytes, and macrophages via an unknown receptor. PCV utilizes ClaME to enter the cell,
though other pathways may be involved (69, 70). In contrast, although a dynamin- and cho‐
lesterol-independent, but actin- and small GTPase-dependent pathway, allows PCV2 inter‐
nalization in epithelial cells that leads to infection, a clathrin-mediated PCV2 internalization
in epithelial cells is not followed by a full replication (69). Recent evidence suggests dendrit‐
ic cells (DC) are involved through their particularly elevated endocytosis of the virus. PCV2
can accumulate to high levels both in vitro and in vivo, a phenomenon dependent on the vi‐
rus capsid protein, inferring that the viral capsid or genome impedes DC endocytic degrada‐
tion of the virus (71). However, PCV2 in DC does not interfere with processing of other
antigens.
4.3.2. Endocytosis of parvoviruses
Most Parvoviridae family members were shown to enter cells by ClaME (39, 72, 73). When
investigating early steps of infection of porcine parvovirus (PPV), we found that inhibition
of ClaME affected PPV infection, but we could not achieve complete inhibition (39). Inhibi‐
tion of fluid phase endocytosis components also reduced PPV infection. Interestingly combi‐
nation of inhibition of both pathways reduced more the infection level, but still, some cells
could be infected, suggesting a third pathway might be involved. It is important to consider
the fact that inhibition of endocytosis pathways will result in upregulation of compensatory
mechanisms that can influence viral infection. Laboratory experiments often use highly-pu‐
rified viruses. We demonstrated, however, that after replication most PPV is present in ag‐
gregates which used preferentially fluid phase endocytosis, compared to the purified
isolated particles that preferred ClaME (39). Purified viral preparations might not reflect the
actual mode of infection inside the host. In vivo, aggregates are likely to form and be in‐
volved in further infection of other cells.
Adeno-associated viruses (AAVs) are members of the Dependovirus genus. They cannot com‐
plete their replication cycle without a helper virus, such as adenovirus. Many groups study
AAVs entry and genome delivery in the nucleus, since they represent a good platform for
gene therapy. However, the early steps of infection are not efficient (just like all parvovirus‐
es) and a better understanding of the mechanism involved could lead to genetically modi‐
fied viruses that are better suited for gene delivery. AAV5 can enter cells via ClaME (32), but
it was shown to be able to use CavME too (32). To date, it is the only known parvovirus us‐
ing this pathway. The authors observed the virus in non-coated vesicles using TEM. These
vesicles contained caveolin-1. This pathway could not be found in all cell types, highlighting
the fact that specific cargos can use different pathways depending on the cell type.
CLIC-GEEC (CLathrin-Independent Carrier/GPI-anchored protein-Enriched Endosomal
Compartment) is a clathrin/caveolin independent entry pathway, identified in the past 10
years Figure 3. This pathway is constitutive, and thus attractive for pathogens. The size and
shape of the vesicles can vary greatly, and could potentially accommodate large or multiple
viruses. An important protein is GRAF1, serving as a marker or by inhibiting the pathway
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by gene silencing. Another interesting feature of the pathway, for viruses, is that resulting
vesicles will acidify, and can provide proper environment for conformational changes.
Figure 3. CLIC-GEEC entry mechanism. Characteristic features of this endocytosis mechanism include location in the
lipid rafts, tubular shaped, large, pleomorphic invaginations, taking up large volume of membrane and fluids. Those
required actin polymerisation involving Cdc42, and membrane curvature involving Arf1. GRAF-1 is a key player that
can be used as marker or as target to inhibit this mechanism of uptake.
Adeno-associated viruses type 2 (AAV2) endocytosis was recently extensively studied, and
revealed a complex mechanism (33). This endocytosis was independent of clathrin and cav‐
eolin. Also, only one known inhibitor (EIPA) of macropinocytosis could affect the entry of
the virus. This inhibitor was shown to inhibit Rac1 and Cdc42 signaling, thus affecting other
mechanisms as well (74). This endocytosis required actin cytoskeleton and cholesterol.
Membrane and actin remodeling was observed by TEM and immunofluorescence, respec‐
tively. Virus bound to the cell surface was located in lipid rafts. These features led to the re‐
cently described CLIC/GEEC pathway (38). Dominant negative mutants revealed the critical
role of Arf1 and Cdc42 for AAV2 endocytosis (33). GRAF1 (GTPase Regulator Associated
with Focal adhesion kinase) was also demonstrated to be essential in CLIC-GEEC endocyto‐
sis, and postulated to act as a “coat” for that pathway (38). Expression of a truncated mutant
of the protein, as well as the use of siRNA, both reduced the endocytosis of AAV2 (33).
GRAF-1 is not implicated in ClaME or CavME, and thus appears specific to CLIC-GEEC en‐
docytosis. Combination of GRAF1 and dynamin inhibition further diminished entry of
AAV2, confirming that both proteins are important for endocytosis of AAV2. Interestingly,
endosomes of the CLIC-GEEC pathway are known to acidify quickly and inhibition of acidi‐
fication reduced transduction by AAVs (33). Then the virus is transported to the Golgi appa‐
ratus, and no co-localisation is observed with endosomal markers (Rab proteins).
4.3.3. Endocytosis of polyomaviruses
SV40 is probably the best described virus using CavME (75). Initial observations were made
by electron microscopy (TEM) where the virus was not present in a coated vesicle, as op‐
posed to ClaME. Entry is dependent of cholesterol, actin polymerization, dynamin and cav‐
eolin (37, 76). SV40 provides a good example of a particular traffic that does not involve
classical endosomal pathway (37). Virus can be a great tool when used as a tracer for the
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endocytosis pathway, by using fluorescent viruses and either regular confocal microscopy
or live imaging. Pelkmans et al. showed that SV40 traffic to the ER in two distinct steps (37).
They saw, using live imaging that the virus once bound to its receptor will move on the sur‐
face of the cell until it reach the caveolae. Then the virus is endocytosed into very small vesi‐
cles. These will transport the virus to larger vesicle already present in the cytoplasm. These
vesicle contained several virus particle and were caveolin-positive (“caveosomes”). Then the
virus left the caveosomes in tubular-shaped small vesicles that moved along the microtu‐
bules toward the nucleus. The virus was then delivered to the smooth ER. No co-localisation
with clathrin was observed, and inhibition of ClaME does not affect SV40 infection. SV40
was also reported to infect cells that do not express caveolin (77). In these cells, entry in‐
volved tyrosine kinases and cholesterol but again was not dependent of clathrin or dynamin
(77). Entry could not be reduced when inhibiting ClaME or macropinocytosis. It was also
faster than regular CavME, but led to the ER in a microtubule dependent manner similar to
CavME. This is a good example of virus adaptation, enabling infection in a wide range of
cells. In caveolae-expressing cells, both pathways are used. They share important character‐
istics such as dependence of cholesterol, tyrosine kinases and transit in neutral vesicles us‐
ing the microtubule network leading to the ER (77).
BK virus is a polyomavirus that poses serious health problems (78). It causes diseases in im‐
munosuppressed patients after renal transplants. Immunosuppression therapy can enable
usually non-threatening viruses to replicate easily leading to diseases. More than 80% of the
population has been infected often at young age and latent infection of the kidney is present
in 50% of the population. Efforts are being made to understand infection by this virus. It was
demonstrated that it hijacks CavME, as its relative virus SV40. Cholesterol depletion effi‐
ciently inhibited infection. Knock-down of caveolin-1 by siRNA inhibited the infection,
while a knockout of clathrin had no effect. Immunofluorescence and co-localisation with
confocal microscopy confirmed that BK virus use CavME in cell culture (78-80).
4.3.4. Endocytosis of papillomaviruses
Papillomaviruses are a good example of different family members using different entry
pathways even after binding to similar receptors, thus co-receptors could shunt the virus to
different pathways. BPV1 entered cells by ClaME (81), and HPV31 preferred CavME (82). To
determine which pathway was important they used chemical inhibitors, dominant-negative
mutants and TEM. Another publication showed that for HPV16 and HPV31 macropinocyto‐
sis was important in NK cells (83). In this case, membrane ruffling was observed when the
cells were incubated with the virus-like particles (VLPs). Then, co-uptake of fluid phase was
demonstrated with fluorescent dextran. Inhibition by chemical inhibitors prevented this flu‐
id-phase uptake. In term of RhoGTPases, HPV VLPs induced activation of Cdc42 and inhibi‐
tion of Rac1. Papillomaviruses are highly asynchronous and their pathways chosen are
disputes in the literature.
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4.3.5. Endocytosis of adenoviruses
Adenovirus could be observed in clathrin-coated vesicles by TEM (84). It is also present in
non-coated vesicles. Dominant-negative constructs confirmed the ClaME (55). The involve‐
ment of integrins (85, 86) suggests that adenovirus endocytosis is highly regulated. These in‐
tegrins activate PI(3)K which in turn induces actin polymerization and promotes adenovirus
endocytosis (87). Another observation was that fluid uptake (macropinocytosis) increased
with adenovirus infection (55). Amiloride was effective to inhibit infection. This additional
infection pathway also required actin, small Rho GTPases and PKC.
4.3.6. Endocytosis of iridoviruses
The enveloped form of the iridovirus FV3 (genus Ranavirus) was discovered in early 1980s
by TEM research, and shown to be internalized by ClaME whereas the naked particles were
suggested to enter by fusion at the plasma membrane (29, 88). This model was questioned in
recent reports with a closely related virus (TFV) and the ISKNV virus (89, 90) with both
pointing to caveolae-dependent endocytosis. However, caution is warranted since infection
of cells from non-physiological host, i.e. BHK-21, may cloud a direct comparison of TFV and
FV3 entry. Similar studies coupled with TEM could resolve these issues. The TFV iridovirus,
a ranavirus nearly identical to FV3, enters cells by an atypical, pH-dependent, CavME path‐
way. Experiments using chlorpromazine and over-expression of a dominant-negative form
of Esp15 that inhibited assembly of clathrin-coated pits did not affect entry into HepG2 cells.
Also, endocytosis of TFV was dependent on membrane cholesterol and was blocked by cav‐
eolin-1 scaffolding domain protein. Therefore, Guo et al. suggested that FV3, since its nearly
identical in nucleotide sequence to TFV, may also enter via CavME. Later, these authors
demonstrated that ISKNV, a fish iridovirus, enters fish cells also via CavME since inhibitors
of ClaME had no effect on infection, in contrast to inhibitors of caveolin-1-involved signal‐
ing events (90). Moreover, ISKNV co-locates with caveolin-1 during virus infection and is
dependent on dynamin and the microtubule cytoskeleton.
5. Virus maturation and endosomes escape
Non-enveloped viruses display a variety of strategies to gain access to the cytoplasm of the
cell. Conformational changes are required in capsids to expose hydrophobic domains that
anchor or disrupt the endosomal membrane during breaching. Parvoviruses have acquired
an enzyme for membrane translocation. Virus trafficking is therefore highly temporally and
spatially regulated and a plethora of tools have been developed to study these events.
5.1. Endosomal trafficking of circoviruses and escape to cytoplasm
PCV2 enters monocytic cells predominantly by ClaME and requires an acidic environment
for infection. After endosomal escape, the virus aggregates in intracytoplasmic inclusion
bodies (ICIs). Subsequently, PCV2 closely associates with mitochondria, completing a first
Endocytosis of Non-Enveloped DNA Viruses
http://dx.doi.org/10.5772/45821
19
cytoplasmic phase and enters the nucleus for replication (91). In epithelial cells, PCV2 is in‐
ternalized via a clathrin-, caveolae-, and dynamin-independent small GTPase-regulated
pathway (69).The latter leads to a more efficient PCV2 replication while the former seems to
trap PCV2 leading to accumulation of the virus within epithelial cells. Inhibition of acidifica‐
tion of the endosomal/lysosomal system reduces PCV2 infection of the monocytic cells, indi‐
cating the requirement for a pH drop during replication. Surprisingly, inhibiting
acidification highly increases PCV2 replication in epithelial cells, indicating that uncoating
occurs at another pH. Serine proteases mediate PCV2 uncoating in both epithelial cells and
cells of the monocytic cells but may have different optima in these cells (92). It is not clear
how this uncoating process impacts on the endosomal escape.
5.2. Endosomal trafficking of parvoviruses and escape to cytoplasm
Parvoviruses have a unique enzyme domain, phospholipase A2, in their capsid (12, 13, 93).
This protein domain with this motif is located inside the mature virion, and thus the virus
needs to undergo a conformational change in order to expose and use this enzyme. The pen‐
tamer at the fivefold symmetry axis has a 0.8 nm central pore and is itself encircled by a 1.5
nm-deep depression (“canyon”). The hairpins of the central cylinder (see section 2.1.2) can
thus move outward leading to a greater pore and allowing N-termini of VP2, during the
transit in the endosome and acidification (94), to become exposed one by one and their N-
termini proteolytically cleaved, yielding successively a larger pore. The internal unique part
of VP1 (that resists proteolysis) is then able to externalize and expose its phospholipase A2
domain. Phospholipases catalyze hydrolysis of phospholipids, providing a means to breach
the endosomal barrier. This motif is absolutely essential for parvoviruses infection and acts
prior to the delivery of the genome to the nucleus (13). Millimolar calcium concentrations
present in the endosome but not in the cytosol, are required for optimal activity of the en‐
zyme (12). Since it was required after accumulation of the virus in the perinuclear region,
but prior to DNA expression in the nucleus, it was hypothesized that its role could be the
ensodomal escape. Co-uptake studies showed that small dextran particles, but not α-sarcin,
could be released from the endosomes together with parvovirus escape. These observations
suggested that parvovirus escape implicated small pore formation and not broad endosome
disruption. Viruses harboring mutations in the PLA2 enzymatic domain remained trapped
in endosomes in perinuclear areas, but could be complemented in trans in co-infection ex‐
periments with wild-type capsids (93). Moreover, induced endosomes disruption induced
by treatment of the cells with polyethylenimine (PEI) was enough to rescue the infection,
strongly suggesting that the main function of PLA2 is the escape of the virus from the enso‐
somal pathway.
5.3. Endosomal trafficking of polyomaviruses and escape to cytoplasm
SV40 enters via caveolin-1 containing vesicles that budded from the caveolae and that are
transferred to caveosomes (lack markers for endosomes, lysosomes, ER and Golgi) (37).
SV40 is then transferred from caveolin-free, tubular vesicles to the ER via an intermediate
COP1 compartment that is brefeldin A-sensitive (95). Interestingly, polyomavirus is deliv‐
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ered to early endosomes and a crosstalk between ClaME and CavME has been reported for
JCV (96). Nevertheless, after passage through early endosomes these are sorted to caveo‐
somes. Escape occurs from the ER to the cytosol before reaching the nucleus (97). An elegant
and elaborate study in an attempt to describe mechanisms involved in this escape was pub‐
lished in 2011 (97). TEM studies suggested profound conformational changes in the ER
where the capsid diameter decreased from 45nm to 34nm. These conformational changes led
to exposing structural protein VP2, which was not accessible in the mature virion that en‐
tered the cell. This VP2 protein contains hydrophobic structures that interact with the ER
membrane. In the absence of VP2, the capsid can be targeted to the ER, but would not be
able to transit back to the cytosol. There are several cellular proteins essential for SV40 es‐
cape to the cytosol. BAP31, highly-abundant membrane protein of the ER, is essential for
SV40 infection. The chaperone BiP is also important for the escape, and will play its role af‐
ter BAP31-induced conformational changes in the capsid suggesting that the ERAD-factors
(isomerases, Derlin) assist is in SV4 ER- cytosol dislocation as used for misfolded proteins
(97).
5.4. Endosomal trafficking of papillomaviruses and escape to cytoplasm
This subject is, due to the lack of suitable study models, still controversial. Conformational
changes occur quickly after HPV entry and capsid protein L1 conformational epitope be‐
comes inaccessible after endocytosis (44). Uncoating can be observed by L2 detection (nor‐
mally buried and inaccessible in mature virions), or DNA detection. Papillomavirus escape
from the endosomal pathway, at a relatively early stage, and only partial co-localisation be‐
tween the virus and the lysosome can be seen (44, 98). Structural protein L2 is a major player
in the escape. The protein has a hydrophobic C-terminal, adjacent to positively-charged resi‐
dues, believed to destabilize the membrane structure and leading to disruption. It was re‐
cently described that the cellular protein nexin-17 was also important (98). The suggested
role of this protein is to retain the virus in the late endosomes, preventing degradation in the
lysosomes. When this protein is knocked down, strong co-localisation of the virus with the
lysosomes was observed. Importantly, the binding sequence in L2 protein is conserved
among Papillomaviridae family, both for low- and high-risk viruses. Recent studies suggested
that BPV1 and human papillomavirus type 16 (HPV16, the most common etiological agent
of cervical cancer) enter via ClaME, but that subsequent steps, as for JCV polyomavirus, re‐
quire caveolin-1-mediated trafficking (81, 99). This novel trafficking may explain the re‐
quirement for the CavME pathway because ClaME typically does not lead to the ER.
5.5. Endosomal trafficking of adenoviruses and escape to cytoplasm
During entry, fibers are released, the penton base structures dissociated, the proteins con‐
necting the DNA to the inside surface of the capsid degraded or shed, and the capsid-stabi‐
lizing minor proteins eliminated (100). The uncoating process starts immediately upon
endocytic uptake with the loss of fibers and ends with the uptake of dissociated hexon pro‐
teins and DNA into the nucleus. For the adenoviruses, the escape will occur quickly, and is
postulated to be as early as the sorting endosomes (48). An acidic pH is not sufficient for
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conformational changes in the virus structure to occur but a large number of factors, such as
integrin, are involved (101). Integrin binding together with CAR-mediated drifts supported
fiber shedding from adenovirus particles, leading to exposure of the membrane-lytic inter‐
nal virion protein VI and enhanced viral escape from endosomes (102). The Ts1 mutant,
which lacks the viral protease and cannot process the capsid or release the fibers during en‐
dosomal trafficking, will not be able to breach the endosomal membrane and ends up in ly‐
sosomes where it is degraded (103).
For subgroup B adenoviruses, Kalin et al. showed by confocal laser scanning microscopy,
electron microscopy, and live cell imaging (104) that Ad35 colocalized with fluid-phase
markers in large endocytic structures that were positive for CD46, alphanu integrins, and al‐
so CtBP1 (89).Their results extended observations with HAdV-3 (Ad3), using chemical in‐
hibitors and dominant-negative mutants, that macropinocytosis is an infectious pathway for
subgroup B human adenoviruses in epithelial and hematopoietic cells.
5.6. Endosomal trafficking of irdoviruses and escape to cytoplasm
Maturation of iridoviruses during entry has not been investigated in detail. The minor zip
and finger proteins may play an essential role for capsid destabilization. Uncoating may oc‐
cur at the nuclear membrane but, unlike herpesviruses, iridovirus genomes are not infec‐
tious, indicating that virion-associated proteins are required to initiate viral gene
transcription (105). Early EM studies showed that FV3 ended up in the lysosome (88); how‐
ever this may be a non-productive pathway. It has been suggested that ISKNV traffics via
the caveosome to the ER, similar to SV40, and TFV via the caveosome to the trans-Golgi (89,
90). Chitnis et al. demonstrated that apoptosis induction by CIV iridovirus : (i) requires en‐
try and endocytosis of virions or virion proteins, (ii) is inhibited under conditions permitting
early viral expression, and (iii) requires the JNK signaling pathway (106). Apoptosis was in‐
hibited by Z-IETD-FMK, an apical caspase inhibitor, indicating that CIV-induced apoptosis
requires caspase activity. The JNK inhibitor SP600125 demonstrated drastic suppression of
CVPE-induced apoptosis and showed that the JNK signaling pathway is significant for
apoptosis in this system. Virus interaction with the cell surface was not sufficient for apopto‐
sis since CIV(UV) particles bound to polysterene beads failed to induce apoptosis. Further‐
more, blocking viral DNA replication with aphidicolin or phosphonoacetic acid suppressed
apoptosis and Cf-caspase-i activity, indicating that early viral expression is necessary for in‐
hibition of apoptosis, and de novo synthesis of viral proteins is not required for induction.
6. Conclusions
Endocytosis is a wide subject that has been studied for a very long time. Viruses are definite‐
ly great tool to study endocytosis since they are masters in hijacking every single possibility
of the cell to achieve infection. Elucidating steps in viral replication often leads to hitherto
unknown mechanisms that expand our knowledge of normal cellular processes. It is also in‐
teresting to realise that significant differences are found inside a family of closely related vi‐
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ruses. Co-evolution with different hosts, in different conditions pushed viruses to adapt in
different direction and provide a great variety of tools. However, in the case of life threaten‐
ing or economically-important viruses, it is sometimes very hard to find a way to prevent
infection without impeding with normal cellular processes. This growing field of research
will surely provide new exiting insights to previously unknown cellular process, and will
continue to provide good targets for antiviral drugs.
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